Cytosorbents Corp. (CTSO)

Health Care·equity
$3.79
+1.61% today
Prices delayed about 15 minutes · cached page, can be an hour old or more
Market Census Score
26/ 100
Score level
Below average
6 of 6 checks had data

Score for how it compares with the broader market is near the bottom of its range; price trend is one of its lowest-scoring factors; and smart-money score is near the top of its range.

CTSO scores higher than 22% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Cytosorbents Corp. (CTSO) scores 26 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated · scores usually change about once a day

TrendStrengthFinancialsInsidersMarketMomentum26/ 100

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume
0.28× 30-day average
52-week range
3.59 – 20.00
Market cap
$18.12M
Earnings date
3 Nov 2026
Volume
6,233
Avg. volume (30d)
22,062
Open
3.67
Previous close
3.73
Day's range (regular session)
3.59 – 3.80

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta
1.31
P/E (TTM)
—
EPS (TTM)
-0.29

Score breakdown · six named factors

Price trend
5
Strength vs the market
0
Company finances
15
Insider trades
90
Market mood
50
Recent momentum
17

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for CTSO

  • 7 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for CTSO. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about CTSO right now

Cytosorbents Corp. (CTSO) currently scores 26/100 on the Market Census six-factor composite, at the Below average score level. CTSO is +1.61% on the day and -6.42% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of CTSO's data reads poorly than well. The level is a "look before you act" flag. It is not advice. CTSO's strongest factor is insider trades at 90/100 — a very strong read on insider buying and selling. Insider filings currently lean toward buying on this name — a plain read of public filings, not a signal to follow. The weakest factor is strength vs the market at 0/100 — well below average next to the wider market.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See CTSO in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Recent CTSO news

Latest headlines that name Cytosorbents, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).

Saved snapshot; the news and prices on this page can be an hour old or more.

Similar setups in Health Care right now

Six health care tickers whose composite scores are closest to CTSO’s 26, all within 1 point.

Sorted by closeness to CTSO’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →

Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.